| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2024 | Mar 4, 2024 | TALPHERA, INC. | Chief Medical Officer | Sell | 50.0 | -450 | -0.76% | ✗ | $585 |
| Feb 10, 2024 | Feb 13, 2024 | TALPHERA, INC. | Chief Medical Officer | Sell | 47.5 | -1,602 | -4.34% | ✗ | $1.8K |
| Aug 24, 2023 | Aug 25, 2023 | TALPHERA, INC. | Chief Medical Officer | Sell | 26.3 | -16,956 | -35.54% | ✗ | $19.2K |
| Mar 3, 2023 | Mar 6, 2023 | TALPHERA, INC. | Chief Medical Officer | Sell | 47.5 | -570 | -1.30% | ✗ | $746.7 |
| Feb 10, 2023 | Feb 14, 2023 | TALPHERA, INC. | Chief Medical Officer | Sell | 90.0 | +5,108 | 13.17% | ✗ | $1.7K |
| Feb 6, 2023 | Feb 8, 2023 | TALPHERA, INC. | Chief Medical Officer | Sell | 47.5 | -681 | -1.73% | ✗ | $1.4K |
| Mar 3, 2022 | Mar 4, 2022 | TALPHERA, INC. | Chief Medical Officer | Sell | 47.5 | -7,923 | -1.01% | ✗ | $3.2K |
| Feb 11, 2022 | Feb 14, 2022 | TALPHERA, INC. | Chief Medical Officer | Sell | 90.0 | +114,573 | 17.29% | ✗ | $3.2K |
| Feb 6, 2022 | Feb 7, 2022 | TALPHERA, INC. | Chief Medical Officer | Sell | 47.5 | -9,391 | -1.40% | ✗ | $4K |
| Feb 11, 2021 | Feb 12, 2021 | TALPHERA, INC. | Chief Medical Officer | Sell | 46.3 | -8,915 | -1.48% | ✗ | $23.4K |
| Feb 6, 2021 | Feb 9, 2021 | TALPHERA, INC. | Chief Medical Officer | Sell | 46.3 | -9,414 | -1.54% | ✗ | $24.4K |
| Feb 11, 2020 | Feb 13, 2020 | TALPHERA, INC. | Chief Medical Officer | Sell | 46.3 | -7,924 | -1.29% | ✗ | $13.6K |
| Feb 28, 2019 | Mar 4, 2019 | TALPHERA, INC. | Chief Medical Officer | Buy | 55.0 | +840 | 0.16% | ✗ | $2.4K |
| Nov 19, 2018 | Nov 19, 2018 | TALPHERA, INC. | Chief Medical Officer | Buy | 83.8 | +16,000 | 3.51% | ✗ | $49.1K |
| Aug 6, 2018 | Aug 6, 2018 | TALPHERA, INC. | Chief Medical Officer | Buy | 90.0 | +37,000 | 8.83% | ✗ | $101.8K |
| Aug 22, 2017 | Aug 22, 2017 | TALPHERA, INC. | Chief Medical Officer | Buy | 78.8 | +10,000 | 2.46% | ✗ | $29.5K |
| Jun 9, 2011 | Jun 13, 2011 | TALPHERA, INC. | Chief Medical Officer | Buy | 83.8 | +8,800 | 2.77% | ✗ | $40.6K |